These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1852515)

  • 1. Benefits and complications of troleandomycin (TAO) in young children with steroid-dependent asthma.
    Flotte TR; Loughlin GM
    Pediatr Pulmonol; 1991; 10(3):178-82. PubMed ID: 1852515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of corticosteroid side effects in chronic steroid-dependent asthmatics on TAO (troleandomycin) and methylprednisolone.
    Harris R; German D
    Ann Allergy; 1989 Aug; 63(2):110-1. PubMed ID: 2788376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved protocol for the use of troleandomycin (TAO) in the treatment of steroid-requiring asthma.
    Wald JA; Friedman BF; Farr RS
    J Allergy Clin Immunol; 1986 Jul; 78(1 Pt 1):36-43. PubMed ID: 3487564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of low-dose troleandomycin on glucocorticoid pharmacokinetics and airway hyperresponsiveness in severely asthmatic children.
    Ball BD; Hill MR; Brenner M; Sanks R; Szefler SJ
    Ann Allergy; 1990 Jul; 65(1):37-45. PubMed ID: 2195921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose- and time-related effect of troleandomycin on methylprednisolone elimination.
    Szefler SJ; Brenner M; Jusko WJ; Spector SL; Flesher KA; Ellis EF
    Clin Pharmacol Ther; 1982 Aug; 32(2):166-71. PubMed ID: 6980076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylprednisolone and troleandomycin in treatment of steroid-dependent asthmatic children.
    Eitches RW; Rachelefsky GS; Katz RM; Mendoza GR; Siegel SC
    Am J Dis Child; 1985 Mar; 139(3):264-8. PubMed ID: 3872062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids.
    Nelson HS; Hamilos DL; Corsello PR; Levesque NV; Buchmeier AD; Bucher BL
    Am Rev Respir Dis; 1993 Feb; 147(2):398-404. PubMed ID: 8430965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of low-dose troleandomycin therapy in children with severe, steroid-requiring asthma.
    Kamada AK; Hill MR; Iklé DN; Brenner AM; Szefler SJ
    J Allergy Clin Immunol; 1993 Apr; 91(4):873-82. PubMed ID: 8473676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of troleandomycin on methylprednisolone elimination.
    Szefler SJ; Rose JQ; Ellis EF; Spector SL; Green AW; Jusko WJ
    J Allergy Clin Immunol; 1980 Dec; 66(6):447-51. PubMed ID: 6968763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troleandomycin in the treatment of difficult asthma.
    Siracusa A; Brugnami G; Fiordi T; Areni S; Severini C; Marabini A
    J Allergy Clin Immunol; 1993 Nov; 92(5):677-82. PubMed ID: 8227858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of TAO without methylprednisolone in the treatment of severe asthma.
    Rosenberg SM; Gerhard H; Grunstein MM; Schramm CM
    Chest; 1991 Sep; 100(3):849-50. PubMed ID: 1889284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of low-dose troleandomycin on theophylline clearance: implications for therapeutic drug monitoring.
    Kamada AK; Hill MR; Brenner AM; Szefler SJ
    Pharmacotherapy; 1992; 12(2):98-102. PubMed ID: 1570234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal varicella in a corticosteroid-dependent asthmatic receiving troleandomycin.
    Lantner R; Rockoff JB; DeMasi J; Boran-Ragotzy R; Middleton E
    Allergy Proc; 1990; 11(2):83-7. PubMed ID: 2338242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of troleandomycin in outpatients with severe, corticosteroid-dependent asthma.
    Zeiger RS; Schatz M; Sperling W; Simon RA; Stevenson DD
    J Allergy Clin Immunol; 1980 Dec; 66(6):438-46. PubMed ID: 6968762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid-specific and anticonvulsant interaction aspects of troleandomycin-steroid therapy.
    Szefler SJ; Ellis EF; Brenner M; Rose JQ; Spector SL; Yurchak AM; Andrews F; Jusko WJ
    J Allergy Clin Immunol; 1982 May; 69(5):455-60. PubMed ID: 6978898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experiences with a combination therapy of methylprednisolone and troleandomycin in severe bronchial asthma requiring high-dose corticoids].
    Menz G; Rothe T; Schmitt M; Schmitz M; Hauser F; Haack D; Virchow C
    Pneumologie; 1990 Feb; 44 Suppl 1():238-40. PubMed ID: 2367377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of troleandomycin as a steroid-sparing agent in both asthma and chronic obstructive pulmonary disease.
    Shivaram U; Cash M
    J Assoc Acad Minor Phys; 1991; 2(3):131-3. PubMed ID: 1809456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troleandomycin effects on methylprednisolone and methylprednisone interconversion and disposition in the rabbit.
    Ebling WF; Rich SA; Szefler SJ; Jusko WJ
    Eur J Drug Metab Pharmacokinet; 1987; 12(1):50-7. PubMed ID: 3497038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of methylprednisolone elimination in the presence of erythromycin therapy.
    LaForce CF; Szefler SJ; Miller MF; Ebling W; Brenner M
    J Allergy Clin Immunol; 1983 Jul; 72(1):34-9. PubMed ID: 6602160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonantibiotic effects of macrolide antibiotics of the oleandomycin-erythromycin group with special reference to their "steroid-sparing" effects.
    Selenke WM; Leung GW; Townley RG
    J Allergy Clin Immunol; 1980 Jun; 65(6):454-64. PubMed ID: 6966289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.